Nasdaq Stockholm

Diamyd Medical AB

ISIN SE0005162880Filings at the FI

At a glance

Most recent filing on July 27, 2026 — an open-market purchase by Anders Essen-Möller on Jul 27, 2026.

We hold 47 visible filings, going back to November 20, 2018.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 47 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 47. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Anders Essen-Möller Chief executive officer
97,700 SEKOpen-market buy
TradedJul 27, 2026FiledJul 27, 2026
Anders Essen-Möller Chief executive officer
100,000 SEKOpen-market buy
TradedJun 24, 2026FiledJun 24, 2026
Anders Essen-Möller Chief executive officer
104,000 SEKOpen-market buy
TradedApr 29, 2026FiledApr 30, 2026
Anders Essen-Möller Chair of the board
100,000 sharesOther
TradedJun 26, 2025FiledJun 27, 2025
Anders Essen-Möller Chair of the board
3,485,040 SEKGrant
TradedApr 30, 2025FiledMay 2, 2025